As Ozlo’s Sleepbuds go on sale, company raises funds for tinnitus treatment

Ozlo releases $299 Sleepbuds, raises $12M for tinnitus treatment.

: Ozlo launches Sleepbuds, designed by former Bose execs, at $299, emphasizing streaming capability. The company also raised $12 million to advance Sleepbuds and seek FDA-clearance for tinnitus treatment, led by LifeArc Ventures. Despite some initial wireless connection issues, the Sleepbuds improve sleep quality with ambient music.

Ozlo, founded by former Bose executives, has introduced its new Sleepbuds priced at $299. After Bose discontinued its Sleepbuds line, Ozlo took up the mantle and improved upon its predecessors by adding streaming capability, filling a significant gap identified in earlier versions.

Alongside this release, the company has successfully secured $12 million in funding, spearheaded by LifeArc Ventures with contributions from Drive by DraftKings, Wise Ventures, and others. These funds will be directed towards developing second-generation Sleepbuds and obtaining FDA-clearance for tinnitus therapy, targeting the 10% of the population affected by this condition.

The Sleepbuds have demonstrated potential in enhancing sleep quality through ambient music streaming. Although minor connectivity issues have been noted, the product has filled a niche for users needing both preloaded sounds and user-defined streaming options, ensuring its place in the evolving wearables market.

Ozlo SleepbudsTinnitus TreatmentWearables